Chronic cough, a persistent and often debilitating condition, presents a clinical challenge for healthcare professionals worldwide. Despite its prevalence, the etiology remains poorly understood, necessitating a comprehensive approach to diagnosis and treatment.
Chronic cough is multifactorial, with common causes including gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, a significant proportion of patients do not respond to treatment for these conditions, indicating a complex underlying etiology.
A thorough patient history and physical examination form the cornerstone of diagnosis. However, additional investigations such as chest X-rays, spirometry, and bronchoscopy may be required in certain cases. Empirical therapy based on the most likely cause can also be a useful diagnostic tool.
Treatment should be tailored to the identified cause. For GERD-related cough, proton pump inhibitors may be effective. Inhaled corticosteroids are often beneficial for asthma-related cough, while antihistamines and decongestants can alleviate UACS-related symptoms. In refractory cases, novel therapies such as speech therapy and neuromodulators are showing promise.
Effective patient education is crucial in managing chronic cough. Patients should be informed about the potential causes and treatment options, and reassured that serious underlying conditions are rare. They should also be encouraged to avoid cough triggers and adhere to prescribed therapies.
Chronic cough, while common, remains an enigmatic condition. A comprehensive approach, incorporating a detailed clinical evaluation, targeted treatment, and effective patient education, is essential for optimal management. As our understanding of chronic cough continues to evolve, healthcare professionals must stay abreast of emerging diagnostic tools and treatment strategies to provide the best possible care for their patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation